MoCRA checklist for Korean beauty brands selling in the US
Work out which MoCRA duties fall on your Korean factory and which fall on the company named on the label, with FDA's deadlines and a dated worked example.

Does MoCRA apply to a Korean brand that sells in the US?
Yes. If your cosmetics are sold in the US, MoCRA applies wherever they are made. The factory registers with FDA and names a US agent. The responsible person, meaning the company named on the label, lists each product, keeps safety records, prints a contact for adverse event reports on the label and reports serious adverse events within 15 business days. FDA charges no fee, and some small businesses are exempt from registration and listing.
MoCRA is the Modernization of Cosmetics Regulation Act of 2022. This checklist covers its duties only, each with the FDA page or section of law that states it, checked on November 11, 2026. FDA's MoCRA page was last updated on October 29, 2026 and three of the law's rules are still not final, so treat each item as dated and confirm it on FDA's page before you rely on it. Customs entry and sunscreen have their own guides, linked where they come up.
This is general information. It is not legal or regulatory advice, and it cannot tell you that a product complies. A US regulatory specialist should confirm how the rules apply to your products.
Who is the responsible person, and who registers the factory?
MoCRA puts duties on two parties, and a Korean brand that uses a contract manufacturer is usually only one of them.
The responsible person is the manufacturer, packer or distributor whose name appears on the product label. FDA's guidance says a company outside the US can be the responsible person as long as it is the one named on the label. So the name you print on the US label decides who carries the listing, safety and reporting duties. Whether to set up a US company for this and other reasons is a separate decision, covered in our guide on when a beauty brand should create a US LLC.
A facility is any establishment that manufactures or processes cosmetics distributed in the US. The guidance says a contract manufacturer outside the US must register, that following ISO 22716 gives no exemption, and that a laboratory doing batch release testing counts as a facility. An establishment that only labels, packages, holds or distributes is outside the definition, so a storage warehouse does not register. One registration covers a facility even when it makes products for several brands, and a responsible person may submit it for the contract manufacturer.
A foreign facility must name a US agent in its registration. The guidance describes the agent as a person or business that resides or keeps a place of business in the US and is physically present there. A mailbox or answering service does not qualify. In a part of the guidance (questions 20 to 22) that FDA marked as distributed for comment only, it describes the agent's responsibilities as limited: helping FDA communicate with the facility, answering questions about its imported products, helping schedule inspections and receiving documents on its behalf.
One FDA page can mislead here. FDA's question-and-answer page for cosmetics importers, last updated November 18, 2025, still says firms importing cosmetics are not required to register and refers to a voluntary program. Our reading is that the statement covers a firm that only imports. The December 2024 guidance puts the registration duty on the facility that makes the product, and says an importer that meets the definition of a facility or a responsible person, with no exemption, must comply.
What is on the MoCRA checklist, and when is each item due?
The table lists eight duties with the party that owns each one. Registration and listing go through Cosmetics Direct, FDA's free electronic portal, or on paper Forms FDA 5066 and 5067. The facility needs an FDA Establishment Identifier (FEI) number before it can register.
Registration is not approval. FDA says a registration or listing number does not mean FDA has approved anything, and on September 9, 2026 it reminded the industry that it does not issue certificates that verify registration. If a retailer or marketplace asks for an FDA certificate, there is none to give. FDA announced on February 11, 2026 that Cosmetics Direct now shows a registration status and a renewal date for each facility. Ask your manufacturer for that record.
MoCRA duties for a cosmetic sold in the US (checked November 11, 2026)
| Duty | Who owns it | When | Where it is written |
|---|---|---|---|
| Register each facility that manufactures or processes the product | The facility's owner or operator. A responsible person may submit it for a contract manufacturer | Within 60 days of first making product for the US. Renew every two years. Update within 60 days of a change | FDA guidance, December 2024 |
| Name a US agent | A facility outside the US | In the facility registration | FDA guidance, December 2024 |
| List each product with its ingredients | The responsible person | Within 120 days of first marketing the product. Update annually | FDA guidance, December 2024 |
| Print a contact for adverse event reports on the label | The responsible person | In effect since December 29, 2024 | 21 USC 364e(a) |
| Keep records that support adequate substantiation of safety | The responsible person | 21 USC 364d sets no period. Ask your specialist how long to keep the file | 21 USC 364d(a) |
| Report serious adverse events to FDA, with a copy of the label | The responsible person | Within 15 business days. New medical information received within a year is due within 15 business days | FDA MoCRA page |
| Keep records of every adverse event report | The responsible person | 6 years, or 3 years for a qualifying small business | 21 USC 364a(e) |
| Label products meant only for licensed professionals | The responsible person | When a product is for professional use only | 21 USC 364e(c) |
Are you exempt as a small business?
Possibly, from three of the eight items: facility registration, the US agent named in that registration, and product listing. FDA's guidance defines a small business as a responsible person, or a facility owner or operator, whose average gross annual sales of cosmetic products in the US over the previous three years are under $1,000,000, adjusted for inflation. A small business is exempt from registration and listing.
The exemption has limits. It does not cover anyone who makes, or is the responsible person for, products that regularly touch the mucous membrane of the eye, products that are injected, products for internal use, or products meant to change appearance for more than 24 hours that the consumer does not remove. FDA's guidance says it expects products applied near the eye, such as eye shadow, eye makeup remover, liquid or mucosal eyeliner and false eyelash adhesive, to touch that membrane regularly, and it says there may be certain exceptions. If you make any of these, or are the responsible person for them, do not count on the exemption.
Our reading of the definition is that the test is applied to each party's own sales. Your brand may be under the line in its first US years while your manufacturer, which supplies many brands, is not. The exemption FDA describes is from registration, listing and the good manufacturing practice rules. The label contact, safety records and adverse event reporting stay on the list for a small brand, with a shorter three-year period for adverse event records. Ask your specialist to confirm the exemption in writing before you rely on it.
What does MoCRA change on the label?
MoCRA adds three label items: one already in force, one for salon products and one that waits on an FDA rule.
Every cosmetic must carry a domestic address, a domestic phone number or electronic contact information, which may be a website, through which the responsible person can receive adverse event reports. That requirement took effect two years after the law was enacted on December 29, 2022. FDA's guidance says an email address or website may be foreign or domestic, and that a fax number or QR code is unlikely to help consumers report. Choose a contact that someone reads every working day, because the 15 business day clock in the checklist depends on it.
A product meant only for licensed professionals must say clearly and prominently that only licensed professionals may use it. The law also requires fragrance allergens to be named on the label once FDA sets the list by regulation, and FDA's page shows no final rule yet.
The older label rules still apply alongside these. FDA's importer page gives missing English labeling and faults in the ingredient declaration as common reasons for refusing a shipment.
What records do you keep, and what do you report?
The responsible person must have adequate substantiation of safety for each product and keep the records that show it. Section 364d names no period for keeping them, so ask your specialist how long to hold the file. FDA says the law does not require specific tests and does not require animal testing, and that manufacturers can use safety data that already exists if it comes from scientifically sound methods. For a brand that buys from a Korean manufacturer, the practical step is to obtain the safety file and keep a copy under the name on the label.
A serious adverse event is one that results in death, a life-threatening experience, inpatient hospitalization, a persistent or significant disability, a birth defect, an infection or significant disfigurement, or one that needs medical or surgical intervention to prevent those outcomes. FDA's definition of disfigurement includes serious and persistent rashes, second or third degree burns and significant hair loss. The report goes to FDA within 15 business days, with a copy of the label, either electronically or on Form FDA 3500A.
Records of every adverse event report, serious or not, are kept for 6 years, or 3 years for a qualifying small business, and FDA can see them during an inspection. FDA can also order a recall when it finds a reasonable probability that a cosmetic is adulterated or misbranded and will cause serious adverse health consequences or death, and the responsible person refuses to recall it voluntarily. The notice announcing FDA's final guidance on mandatory recalls was published in the Federal Register on October 23, 2026, and FDA's MoCRA page lists the guidance under October 29, 2026.
Which MoCRA rules are still not final?
Three, as FDA's MoCRA page stood on its October 29, 2026 update. The law tells FDA to write regulations on good manufacturing practice for cosmetic facilities, on fragrance allergen labeling and on testing talc products for asbestos. For good manufacturing practice the page lists a public meeting and a draft guidance. For fragrance allergens it lists nothing further. FDA proposed the talc testing rule in December 2024 and withdrew it in November 2025.
A guide that gives a date for any of these should link to a final rule. We did not find one on FDA's page, so the checklist above leaves them out.
What if the product is also a drug?
Then MoCRA listing does not apply to it, and stricter rules do. FDA's guidance says a cosmetic that is also a drug is not listed under MoCRA, and a facility that makes only such products does not register under MoCRA unless it also makes ordinary cosmetics. Sunscreen is the common case for Korean brands, and our guide to selling a Korean sunscreen in the US covers that pathway.
Claims can move a product into the drug category without any change to the formula. FDA's importer page gives hair restoration, treatment of acne, dandruff or eczema, and anti-aging effects that involve the structure or function of the skin as examples of claims that make a product a drug in the US. Those claims are written in marketing copy, often translated from a Korean listing.
Dahna does not give legal or regulatory advice. After your specialist sets what each product can say, we can write US product pages, listings and creator briefs inside those limits.
How do the dates work for one product?
The example is invented to show how the deadlines are counted. A Korean brand sells a toner made by a contract manufacturer in Korea, and the brand's own company name is on the US label, so the brand is the responsible person.
The adverse event date in the last row counts from the next business day and assumes no federal holiday falls in the period. That is our counting, and the pages we read do not say how to count the days. Ask your specialist which day starts the clock.
The worksheet has the same rows for your own products, with a column for the evidence behind each answer.
Worked example with invented dates: one toner, one contract manufacturer
| Event (invented) | Rule | Date that follows |
|---|---|---|
| The manufacturer first makes a US batch on December 1, 2026 | Register the facility within 60 days, unless it is already registered | January 30, 2027 |
| The facility registration is submitted on January 20, 2027 | Renew every two years, counted from the first registration date | January 20, 2029 |
| The toner is first marketed in the US on January 15, 2027 | List the product within 120 days | May 15, 2027 |
| The listing is submitted on April 1, 2027 | Update the listing annually, including when a product is discontinued | Each year after the listing |
| A customer reports a hospital stay to the label contact on Wednesday, March 3, 2027 | Report a serious adverse event within 15 business days | March 24, 2027 |
What should you do this week?
Start with the questions that have one-line answers.
The shipment itself has its own preparation, set out in our checklist for importing Korean beauty products. All beauty and K-beauty marketing guides are on one page, including more on rules and importing, and you can see how Dahna works with K-beauty brands once the regulatory groundwork is in place.
- Decide which company name goes on the US label, because that company is the responsible person.
- Ask your manufacturer for its Cosmetics Direct registration status, renewal date and US agent.
- Ask who will submit each product listing, and get the listing confirmation for your files.
- Check the label for a contact that can receive adverse event reports, and name the person who reads it.
- Collect the safety file for each product and store it where the responsible person can produce it.
- Have a US regulatory specialist confirm any small business exemption and review your claims.
In summary
MoCRA applies to cosmetics sold in the US wherever they are made. The factory registers with FDA and names a US agent; the company named on the label lists each product, keeps safety records, prints a contact for adverse event reports and reports serious adverse events within 15 business days.
Sources & further reading
- Modernization of Cosmetics Regulation Act of 2022 (MoCRA), content current as of October 29, 2026 (checked November 11, 2026)U.S. Food and Drug Administration
- Registration and Listing of Cosmetic Product Facilities and Products, content current as of September 9, 2026 (checked November 11, 2026)U.S. Food and Drug Administration
- Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products, December 2024 (checked November 11, 2026)U.S. Food and Drug Administration
- How to Report a Cosmetic Product Related Complaint, content current as of October 5, 2026 (checked November 11, 2026)U.S. Food and Drug Administration
- Cosmetics Importers, content current as of November 18, 2025 (checked November 11, 2026)U.S. Food and Drug Administration
- 21 USC 364a, Adverse events, United States Code 2024 edition (checked November 11, 2026)U.S. Government Publishing Office
- 21 USC 364d, Safety substantiation, United States Code 2024 edition (checked November 11, 2026)U.S. Government Publishing Office
- 21 USC 364e, Labeling, United States Code 2024 edition (checked November 11, 2026)U.S. Government Publishing Office
- 21 USC 364h, Small businesses, United States Code current through Public Law 119-138 (checked November 11, 2026)Office of the Law Revision Counsel, U.S. House of Representatives
- Questions and Answers Regarding Mandatory Cosmetics Recalls; Guidance for Industry; Availability, 91 FR 66851, October 23, 2026 (checked November 11, 2026)Federal Register
Write US copy that stays inside what your specialist approves.
Dahna does not give legal or regulatory advice. Once your regulatory specialist has set what each product can say, Dahna can write the US product pages, listings and creator briefs inside those limits.
This article is general information. It is not legal or regulatory advice.



